A Study of Sativex in the Treatment of Central Neuropathic Pain Due to Multiple Sclerosis

Clinical trial NCT01604265 · COMPLETED

Trial details

NCT number: NCT01604265
Sponsor: Jazz Pharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Multiple Sclerosis Neuropathic Pain

Start date: 2002-03-01
Primary completion: 2002-08-01
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.